Efficacy and safety of biweekly intravenous administrations of the Aurora kinase inhibitor danusertib hydrochloride in independent cohorts of patients with advanced or metastatic breast, ovarian, colorectal, pancreatic, small cell and non-small cell lung cancer: a multi-tumour, multi.institutional Phase II study / Schöffski P; Besse B; Gauler T; de Jonge M J A; Scambia G; Santoro A; Davite C; Jannuzzo M G; Petroccione A; Delord J P. - In: ANNALS OF ONCOLOGY. - ISSN 0923-7534. - 26:3(2014), pp. 598-607.
Titolo: | Efficacy and safety of biweekly intravenous administrations of the Aurora kinase inhibitor danusertib hydrochloride in independent cohorts of patients with advanced or metastatic breast, ovarian, colorectal, pancreatic, small cell and non-small cell lung cancer: a multi-tumour, multi.institutional Phase II study |
Autori: | |
Data di pubblicazione: | 2014 |
Rivista: | |
Handle: | http://hdl.handle.net/11699/8804 |
Appare nelle tipologie: | 1.1 Articolo in rivista |
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.